Request for Covid-19 Impact Assessment of this Report
The United States Gene Therapy Products market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gene Therapy Products market, reaching US$ million by the year 2028. As for the Europe Gene Therapy Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gene Therapy Products players cover Bluebird Bio, Sangamo, Spark Therapeutics, and Dimension Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Ex vivo
In Vivo
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cancer
Monogenic
Infectious disease
Cardiovascular disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapy Products Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gene Therapy Products by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gene Therapy Products by Country/Region, 2017, 2022 & 2028
2.2 Gene Therapy Products Segment by Type
2.2.1 Ex vivo
2.2.2 In Vivo
2.3 Gene Therapy Products Sales by Type
2.3.1 Global Gene Therapy Products Sales Market Share by Type (2017-2022)
2.3.2 Global Gene Therapy Products Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gene Therapy Products Sale Price by Type (2017-2022)
2.4 Gene Therapy Products Segment by Application
2.4.1 Cancer
2.4.2 Monogenic
2.4.3 Infectious disease
2.4.4 Cardiovascular disease
2.4.5 Other
2.5 Gene Therapy Products Sales by Application
2.5.1 Global Gene Therapy Products Sale Market Share by Application (2017-2022)
2.5.2 Global Gene Therapy Products Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gene Therapy Products Sale Price by Application (2017-2022)
3 Global Gene Therapy Products by Company
3.1 Global Gene Therapy Products Breakdown Data by Company
3.1.1 Global Gene Therapy Products Annual Sales by Company (2020-2022)
3.1.2 Global Gene Therapy Products Sales Market Share by Company (2020-2022)
3.2 Global Gene Therapy Products Annual Revenue by Company (2020-2022)
3.2.1 Global Gene Therapy Products Revenue by Company (2020-2022)
3.2.2 Global Gene Therapy Products Revenue Market Share by Company (2020-2022)
3.3 Global Gene Therapy Products Sale Price by Company
3.4 Key Manufacturers Gene Therapy Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gene Therapy Products Product Location Distribution
3.4.2 Players Gene Therapy Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gene Therapy Products by Geographic Region
4.1 World Historic Gene Therapy Products Market Size by Geographic Region (2017-2022)
4.1.1 Global Gene Therapy Products Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gene Therapy Products Annual Revenue by Geographic Region
4.2 World Historic Gene Therapy Products Market Size by Country/Region (2017-2022)
4.2.1 Global Gene Therapy Products Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gene Therapy Products Annual Revenue by Country/Region
4.3 Americas Gene Therapy Products Sales Growth
4.4 APAC Gene Therapy Products Sales Growth
4.5 Europe Gene Therapy Products Sales Growth
4.6 Middle East & Africa Gene Therapy Products Sales Growth
5 Americas
5.1 Americas Gene Therapy Products Sales by Country
5.1.1 Americas Gene Therapy Products Sales by Country (2017-2022)
5.1.2 Americas Gene Therapy Products Revenue by Country (2017-2022)
5.2 Americas Gene Therapy Products Sales by Type
5.3 Americas Gene Therapy Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy Products Sales by Region
6.1.1 APAC Gene Therapy Products Sales by Region (2017-2022)
6.1.2 APAC Gene Therapy Products Revenue by Region (2017-2022)
6.2 APAC Gene Therapy Products Sales by Type
6.3 APAC Gene Therapy Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gene Therapy Products by Country
7.1.1 Europe Gene Therapy Products Sales by Country (2017-2022)
7.1.2 Europe Gene Therapy Products Revenue by Country (2017-2022)
7.2 Europe Gene Therapy Products Sales by Type
7.3 Europe Gene Therapy Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gene Therapy Products by Country
8.1.1 Middle East & Africa Gene Therapy Products Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gene Therapy Products Revenue by Country (2017-2022)
8.2 Middle East & Africa Gene Therapy Products Sales by Type
8.3 Middle East & Africa Gene Therapy Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gene Therapy Products
10.3 Manufacturing Process Analysis of Gene Therapy Products
10.4 Industry Chain Structure of Gene Therapy Products
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gene Therapy Products Distributors
11.3 Gene Therapy Products Customer
12 World Forecast Review for Gene Therapy Products by Geographic Region
12.1 Global Gene Therapy Products Market Size Forecast by Region
12.1.1 Global Gene Therapy Products Forecast by Region (2023-2028)
12.1.2 Global Gene Therapy Products Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gene Therapy Products Forecast by Type
12.7 Global Gene Therapy Products Forecast by Application
13 Key Players Analysis
13.1 Bluebird Bio
13.1.1 Bluebird Bio Company Information
13.1.2 Bluebird Bio Gene Therapy Products Product Offered
13.1.3 Bluebird Bio Gene Therapy Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bluebird Bio Main Business Overview
13.1.5 Bluebird Bio Latest Developments
13.2 Sangamo
13.2.1 Sangamo Company Information
13.2.2 Sangamo Gene Therapy Products Product Offered
13.2.3 Sangamo Gene Therapy Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sangamo Main Business Overview
13.2.5 Sangamo Latest Developments
13.3 Spark Therapeutics
13.3.1 Spark Therapeutics Company Information
13.3.2 Spark Therapeutics Gene Therapy Products Product Offered
13.3.3 Spark Therapeutics Gene Therapy Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Spark Therapeutics Main Business Overview
13.3.5 Spark Therapeutics Latest Developments
13.4 Dimension Therapeutics
13.4.1 Dimension Therapeutics Company Information
13.4.2 Dimension Therapeutics Gene Therapy Products Product Offered
13.4.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Dimension Therapeutics Main Business Overview
13.4.5 Dimension Therapeutics Latest Developments
13.5 Avalanche Bio
13.5.1 Avalanche Bio Company Information
13.5.2 Avalanche Bio Gene Therapy Products Product Offered
13.5.3 Avalanche Bio Gene Therapy Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Avalanche Bio Main Business Overview
13.5.5 Avalanche Bio Latest Developments
13.6 Celladon
13.6.1 Celladon Company Information
13.6.2 Celladon Gene Therapy Products Product Offered
13.6.3 Celladon Gene Therapy Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Celladon Main Business Overview
13.6.5 Celladon Latest Developments
13.7 Vical Inc.
13.7.1 Vical Inc. Company Information
13.7.2 Vical Inc. Gene Therapy Products Product Offered
13.7.3 Vical Inc. Gene Therapy Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Vical Inc. Main Business Overview
13.7.5 Vical Inc. Latest Developments
13.8 Advantagene
13.8.1 Advantagene Company Information
13.8.2 Advantagene Gene Therapy Products Product Offered
13.8.3 Advantagene Gene Therapy Products Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Advantagene Main Business Overview
13.8.5 Advantagene Latest Developments
14 Research Findings and Conclusion
Table 1. Gene Therapy Products Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gene Therapy Products Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Ex vivo
Table 4. Major Players of In Vivo
Table 5. Global Gene Therapy Products Sales by Type (2017-2022) & (K Units)
Table 6. Global Gene Therapy Products Sales Market Share by Type (2017-2022)
Table 7. Global Gene Therapy Products Revenue by Type (2017-2022) & ($ million)
Table 8. Global Gene Therapy Products Revenue Market Share by Type (2017-2022)
Table 9. Global Gene Therapy Products Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Gene Therapy Products Sales by Application (2017-2022) & (K Units)
Table 11. Global Gene Therapy Products Sales Market Share by Application (2017-2022)
Table 12. Global Gene Therapy Products Revenue by Application (2017-2022)
Table 13. Global Gene Therapy Products Revenue Market Share by Application (2017-2022)
Table 14. Global Gene Therapy Products Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Gene Therapy Products Sales by Company (2020-2022) & (K Units)
Table 16. Global Gene Therapy Products Sales Market Share by Company (2020-2022)
Table 17. Global Gene Therapy Products Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Gene Therapy Products Revenue Market Share by Company (2020-2022)
Table 19. Global Gene Therapy Products Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Gene Therapy Products Producing Area Distribution and Sales Area
Table 21. Players Gene Therapy Products Products Offered
Table 22. Gene Therapy Products Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gene Therapy Products Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Gene Therapy Products Sales Market Share Geographic Region (2017-2022)
Table 27. Global Gene Therapy Products Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Gene Therapy Products Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Gene Therapy Products Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Gene Therapy Products Sales Market Share by Country/Region (2017-2022)
Table 31. Global Gene Therapy Products Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Gene Therapy Products Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Gene Therapy Products Sales by Country (2017-2022) & (K Units)
Table 34. Americas Gene Therapy Products Sales Market Share by Country (2017-2022)
Table 35. Americas Gene Therapy Products Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Gene Therapy Products Revenue Market Share by Country (2017-2022)
Table 37. Americas Gene Therapy Products Sales by Type (2017-2022) & (K Units)
Table 38. Americas Gene Therapy Products Sales Market Share by Type (2017-2022)
Table 39. Americas Gene Therapy Products Sales by Application (2017-2022) & (K Units)
Table 40. Americas Gene Therapy Products Sales Market Share by Application (2017-2022)
Table 41. APAC Gene Therapy Products Sales by Region (2017-2022) & (K Units)
Table 42. APAC Gene Therapy Products Sales Market Share by Region (2017-2022)
Table 43. APAC Gene Therapy Products Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Gene Therapy Products Revenue Market Share by Region (2017-2022)
Table 45. APAC Gene Therapy Products Sales by Type (2017-2022) & (K Units)
Table 46. APAC Gene Therapy Products Sales Market Share by Type (2017-2022)
Table 47. APAC Gene Therapy Products Sales by Application (2017-2022) & (K Units)
Table 48. APAC Gene Therapy Products Sales Market Share by Application (2017-2022)
Table 49. Europe Gene Therapy Products Sales by Country (2017-2022) & (K Units)
Table 50. Europe Gene Therapy Products Sales Market Share by Country (2017-2022)
Table 51. Europe Gene Therapy Products Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Gene Therapy Products Revenue Market Share by Country (2017-2022)
Table 53. Europe Gene Therapy Products Sales by Type (2017-2022) & (K Units)
Table 54. Europe Gene Therapy Products Sales Market Share by Type (2017-2022)
Table 55. Europe Gene Therapy Products Sales by Application (2017-2022) & (K Units)
Table 56. Europe Gene Therapy Products Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Gene Therapy Products Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Gene Therapy Products Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Gene Therapy Products Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Gene Therapy Products Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Gene Therapy Products Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Gene Therapy Products Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Gene Therapy Products Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Gene Therapy Products Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Gene Therapy Products
Table 66. Key Market Challenges & Risks of Gene Therapy Products
Table 67. Key Industry Trends of Gene Therapy Products
Table 68. Gene Therapy Products Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Gene Therapy Products Distributors List
Table 71. Gene Therapy Products Customer List
Table 72. Global Gene Therapy Products Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Gene Therapy Products Sales Market Forecast by Region
Table 74. Global Gene Therapy Products Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Gene Therapy Products Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Gene Therapy Products Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Gene Therapy Products Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Gene Therapy Products Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Gene Therapy Products Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Gene Therapy Products Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Gene Therapy Products Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Gene Therapy Products Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Gene Therapy Products Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Gene Therapy Products Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Gene Therapy Products Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Gene Therapy Products Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Gene Therapy Products Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Gene Therapy Products Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Gene Therapy Products Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Gene Therapy Products Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Gene Therapy Products Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bluebird Bio Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 93. Bluebird Bio Gene Therapy Products Product Offered
Table 94. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Bluebird Bio Main Business
Table 96. Bluebird Bio Latest Developments
Table 97. Sangamo Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 98. Sangamo Gene Therapy Products Product Offered
Table 99. Sangamo Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sangamo Main Business
Table 101. Sangamo Latest Developments
Table 102. Spark Therapeutics Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 103. Spark Therapeutics Gene Therapy Products Product Offered
Table 104. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Spark Therapeutics Main Business
Table 106. Spark Therapeutics Latest Developments
Table 107. Dimension Therapeutics Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 108. Dimension Therapeutics Gene Therapy Products Product Offered
Table 109. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Dimension Therapeutics Main Business
Table 111. Dimension Therapeutics Latest Developments
Table 112. Avalanche Bio Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 113. Avalanche Bio Gene Therapy Products Product Offered
Table 114. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Avalanche Bio Main Business
Table 116. Avalanche Bio Latest Developments
Table 117. Celladon Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 118. Celladon Gene Therapy Products Product Offered
Table 119. Celladon Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Celladon Main Business
Table 121. Celladon Latest Developments
Table 122. Vical Inc. Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 123. Vical Inc. Gene Therapy Products Product Offered
Table 124. Vical Inc. Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Vical Inc. Main Business
Table 126. Vical Inc. Latest Developments
Table 127. Advantagene Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 128. Advantagene Gene Therapy Products Product Offered
Table 129. Advantagene Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Advantagene Main Business
Table 131. Advantagene Latest Developments
List of Figures
Figure 1. Picture of Gene Therapy Products
Figure 2. Gene Therapy Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gene Therapy Products Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Gene Therapy Products Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gene Therapy Products Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Ex vivo
Figure 10. Product Picture of In Vivo
Figure 11. Global Gene Therapy Products Sales Market Share by Type in 2021
Figure 12. Global Gene Therapy Products Revenue Market Share by Type (2017-2022)
Figure 13. Gene Therapy Products Consumed in Cancer
Figure 14. Global Gene Therapy Products Market: Cancer (2017-2022) & (K Units)
Figure 15. Gene Therapy Products Consumed in Monogenic
Figure 16. Global Gene Therapy Products Market: Monogenic (2017-2022) & (K Units)
Figure 17. Gene Therapy Products Consumed in Infectious disease
Figure 18. Global Gene Therapy Products Market: Infectious disease (2017-2022) & (K Units)
Figure 19. Gene Therapy Products Consumed in Cardiovascular disease
Figure 20. Global Gene Therapy Products Market: Cardiovascular disease (2017-2022) & (K Units)
Figure 21. Gene Therapy Products Consumed in Other
Figure 22. Global Gene Therapy Products Market: Other (2017-2022) & (K Units)
Figure 23. Global Gene Therapy Products Sales Market Share by Application (2017-2022)
Figure 24. Global Gene Therapy Products Revenue Market Share by Application in 2021
Figure 25. Gene Therapy Products Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Gene Therapy Products Revenue Market Share by Company in 2021
Figure 27. Global Gene Therapy Products Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Gene Therapy Products Revenue Market Share by Geographic Region in 2021
Figure 29. Global Gene Therapy Products Sales Market Share by Region (2017-2022)
Figure 30. Global Gene Therapy Products Revenue Market Share by Country/Region in 2021
Figure 31. Americas Gene Therapy Products Sales 2017-2022 (K Units)
Figure 32. Americas Gene Therapy Products Revenue 2017-2022 ($ Millions)
Figure 33. APAC Gene Therapy Products Sales 2017-2022 (K Units)
Figure 34. APAC Gene Therapy Products Revenue 2017-2022 ($ Millions)
Figure 35. Europe Gene Therapy Products Sales 2017-2022 (K Units)
Figure 36. Europe Gene Therapy Products Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Gene Therapy Products Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Gene Therapy Products Revenue 2017-2022 ($ Millions)
Figure 39. Americas Gene Therapy Products Sales Market Share by Country in 2021
Figure 40. Americas Gene Therapy Products Revenue Market Share by Country in 2021
Figure 41. United States Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Gene Therapy Products Sales Market Share by Region in 2021
Figure 46. APAC Gene Therapy Products Revenue Market Share by Regions in 2021
Figure 47. China Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Gene Therapy Products Sales Market Share by Country in 2021
Figure 54. Europe Gene Therapy Products Revenue Market Share by Country in 2021
Figure 55. Germany Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Gene Therapy Products Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Gene Therapy Products Revenue Market Share by Country in 2021
Figure 62. Egypt Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Gene Therapy Products Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Gene Therapy Products in 2021
Figure 68. Manufacturing Process Analysis of Gene Therapy Products
Figure 69. Industry Chain Structure of Gene Therapy Products
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...